Study demonstrates that the main creators of SARS-CoV-2 mutations are vaccine-suppressed

By | April 14, 2021
A new research paper posted to the medRxiv* preprint server describes the changes in genomic sequence observed during the course of infection in a patient on the drug tacrolimus, along with steroids, both potent immunosuppressants, and who also received convalescent plasma treatment. These mutations were observed to occur within three weeks from infection.